Thermo Fisher Scientific (TMO) Total Current Liabilities (2009 - 2026)

Thermo Fisher Scientific has reported Total Current Liabilities for 18 years, with the latest figure at $15.1 billion in Q2 2026.

• Total Current Liabilities for Q2 2026 came in at $15.1 billion, up 18.49% year-over-year; the trailing twelve-month figure through Jun 2026 was $15.1 billion (up 18.49% YoY), and the FY2025 annual result was $15.2 billion, up 13.93% from the prior year.
• Total Current Liabilities rose to $15.1 billion in Q2 2026, from $14.6 billion in the prior quarter.
• Over five years, Total Current Liabilities peaked at $17.0 billion in Q4 2022 and troughed at $11.0 billion in Q3 2022.
• A 5-year average of $14.0 billion and a median of $14.1 billion in 2023 frame the typical range for Total Current Liabilities.
• The widest annual swing landed in 2022, when Total Current Liabilities soared 72.55%; it then fell 17.62% in 2023.
• A 5-year view of Total Current Liabilities shows it stood at $17.0 billion in 2022, then dropped by 17.62% to $14.0 billion in 2023, then fell by 4.85% to $13.3 billion in 2024, then grew by 13.93% to $15.2 billion in 2025, then dropped by 0.79% to $15.1 billion in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $15.1 billion in Q2 2026, $14.6 billion in Q1 2026, and $15.2 billion in Q4 2025.